Website Header with Language Selector and Dropdowns
Image

Sotorasib Impurity 4


Catalog Number: CL-SRSB-05
CAS No.: 2387708-38-3
Mol.F: C32H36F2N6O4
Mol.W: 606.7
Inv. Status: Custom Synthesis

Chemical Name: Tert-butyl 4-(6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate.

Country of Origin: India

Product Category: Sotorasib Impurities


Sotorasib Impurity 4 is identified by CAS No. 2387708-38-3 and is chemically known as Tert-butyl 4-(6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate.

Sotorasib Impurity 4 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Sotorasib.

Page Keywords: Buy Sotorasib Impurity 4 | Purchase Sotorasib Impurity 4 | Sotorasib Impurity 4 suppliers | Sotorasib Impurity 4 manufacturers | Sotorasib Impurity 4 price | Sotorasib Impurity 4 Importer | Sotorasib Impurity 4 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-SRSB-01
CAS No: 2296729-00-3
Mol Wt: 560.6
Mol F: C30H30F2N6O3
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-02
CAS No: 2484718-65-0
Mol Wt: 506.6
Mol F: C27H28F2N6O2
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-03
CAS No: 2423110-39-6
Mol Wt: 506.6
Mol F: C27H28F2N6O2
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-04
CAS No: 2252403-84-0
Mol Wt: 531
Mol F: C26H32ClFN6O3
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-06
CAS No: 2387555-31-7
Mol Wt: 531
Mol F: C26H32ClFN6O3
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-07
CAS No: NA
Mol Wt: 560.6
Mol F: C30H30F2N6O3
Inv. Status: Custom Synthesis
CAT No: CL-SRSB-08
CAS No: 2252403-56-6
Mol Wt: 560.6
Mol F: C30H30F2N6O3
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.